Skip to content
Home/Companies/Healthcare / CDMO/3P Biopharmaceuticals
3P Biopharmaceuticals

3P Biopharmaceuticals

Healthcare / CDMO·Spain·Active·7yr hold
Entry
2019
Hold
7yr
Status
Active

Who owns 3P Biopharmaceuticals?

3P Biopharmaceuticals has Eurazeo on file as a lender through Eurazeo Private Debt V (2019 vintage), financing since 2019. Its equity owner is not tracked by GP Intel yet.

Hand-verified · updated 2026-04-21

Eurazeo
Investor
Eurazeo
Eurazeo Private Debt V · 2019 · Private Debt

Key facts

HQSpain
SectorHealthcare / CDMO
Websitewww.3pbio.com

More from Eurazeo Private Debt V

Other portfolio companies in the same fund.

Acolad
Acolad
Active
Business ServicesFrance· 2020
Adista
Adista
Active
IT ServicesFrance· 2020
Carre Blanc
Carre Blanc
Active
ConsumerFrance· 2020
NETGO Group
NETGO Group
Active
IT ServicesGermany· 2020
Yieldkit
Yieldkit
Active
AdTechGermany· 2020
YLDA S.P.A.
Ylda S.p.a.
Active
EducationItaly· 2020

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track 3P Biopharmaceuticals

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy 3P Biopharmaceuticals?

2 strategic and 118financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on 3P Biopharmaceuticals.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue